ketoconazole has been researched along with aconitine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bi, YF; Liu, S; Liu, ZQ; Song, FR; Zhang, RX | 1 |
Fu, L; Fu, Y; Li, N; Li, X; Liu, Z; Ni, J; Ou, X; Xu, Y; Yang, C; Zhang, R; Zhao, Z; Zhou, H; Zhu, L; Zuo, H | 1 |
2 other study(ies) available for ketoconazole and aconitine
Article | Year |
---|---|
[Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro].
Topics: Aconitine; Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Ketoconazole; Male; Metabolic Networks and Pathways; Microsomes, Liver; Quinine; Rats; Rats, Sprague-Dawley; Sulfaphenazole; Tandem Mass Spectrometry | 2013 |
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions.
Topics: Aconitine; Animals; Cytochrome P-450 CYP3A; Drug Interactions; Ketoconazole; Membrane Proteins; Mice; Microsomes, Liver; Saccharomyces cerevisiae Proteins | 2022 |